Bolt Biotherapeutics

6 followers


Bolt Biotherapeutics, Inc., based in the San Francisco Bay Area, is a publicly-traded biotechnology company developing Boltbody™ Immune-stimulating Antibody Conjugates (ISAC), a new class of immuno-oncology therapeutics that have eliminated tumors following systemic administration in preclinical stu... Read more

Industries

Employees

51-200

Links

Org chart

Willie Quinn
President & CEO

Willie Quinn

Collapse
Calvin Leung
Senior Director, Corporate Controller
Dawn Colburn
SVP, Clinical Development
Lu Xu
VP, Developmental Science
Michael N. Alonso
VP, Immunology & Pharmacology
Nathan Ihle
Senior Vp, Pharmaceutical Operations
Pam Howland
VP, Portfolio & Program Management
Sarah Nemec
VP, Finance & Principal Accounting Officer
Wesley Burwell
VP, Head of HR
Guifeng Jiang
Head Of Analytical Development